Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_assertion type Assertion NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_head.
- NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_assertion description "[Prompted by the observation of a marked chronic peripheral neuropathy in a patient suffering from rippling muscle disease due to the R26Q caveolin-3 mutation and because TrkA is expressed by neuronal cells and skeletal muscle fibers, we performed a detailed comparative study on the effect of pathogenic caveolin-3 mutants on the signaling and trafficking of the TrkA nerve growth factor receptor and, for comparison, of the epidermal growth factor receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_provenance.
- NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_assertion evidence source_evidence_literature NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_provenance.
- NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_assertion SIO_000772 20472890 NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_provenance.
- NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_assertion wasDerivedFrom befree-2016 NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_provenance.
- NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_assertion wasGeneratedBy ECO_0000203 NP812409.RAUVtGwPJ8lgA9r9o2HyuijQQpemAhMHPYOiGHEBvTTwU130_provenance.